Hideaki Naoe

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Marc Ferrante, Geert D’Haens, Vipul Jairath et al. · The Lancet · 2024 · 76 citations

Moderately-to-severely Active Crohn, Immunology, Gastroenterology +5

LATS1/WARTS phosphorylates MYPT1 to counteract PLK1 and regulate mammalian mitotic progression

Tatsuyuki Chiyoda, Naoyuki Sugiyama, Takatsune Shimizu et al. · The Journal of Cell Biology · 2012 · 55 citations · Full text

Localisation and characterisation of dystrophin in the central nervous system of controls and patients with Duchenne muscular dystrophy.

Miki Uchino, H Teramoto, Hideaki Naoe et al. · Journal of Neurology Neurosurgery & Psychiatry · 1994 · 55 citations · Full text

Neurological Disorder, Pathology, Smooth Muscle +16

Serine protease Omi/HtrA2 targets WARTS kinase to control cell proliferation

Shinji Kuninaka, S-I Iida, Tadayuki Hara et al. · Oncogene · 2006 · 37 citations

Signal Transduction, Signaling Pathway, Cell Regulation +7

Increased EZH2 expression during the adenoma‑carcinoma sequence in colorectal cancer

Mayuko Ohuchi, Yasuo Sakamoto, Ryuma Tokunaga et al. · Oncology Letters · 2018 · 37 citations · Full text